FDA Approves Unknown Drug — ACCORD HLTHCARE
# FDA Approves Generic Drug Application for Accord Healthcare Accord Healthcare received FDA approval for ANDA 214425 on November 13, 2020, expanding its generic pharmaceutical portfolio and positioning the company to capture additional market share in the competitive generic drug sector. The approval enables Accord Healthcare to bring a new generic formulation to market, potentially increasing price competition and improving patient access to affordable medications.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day